<?xml version="1.0" encoding="UTF-8"?>
<p id="par0195">
 <italic>In vitro</italic> data suggest that this class of viruses, and in particular SARS-CoV, uses several strategies to avoid Type I IFN response, both passive and active [
 <xref rid="bib0280" ref-type="bibr">56</xref>,
 <xref rid="bib0295" ref-type="bibr">59</xref>].
 <list list-type="simple" id="lis0015">
  <list-item id="lsti0035">
   <label>-</label>
   <p id="par0200">Passive mechanisms include the induction of double membrane vesicles (DMV) at perinuclear sites within the cytoplasm where RNA synthesis takes place. This strategy may help to hide and protect RNA replication intermediates from being sensed by intracellular RNA-sensors, thus avoiding the activation of the IFN cascade [
    <xref rid="bib0405" ref-type="bibr">81</xref>,
    <xref rid="bib0410" ref-type="bibr">82</xref>].
   </p>
  </list-item>
  <list-item id="lsti0040">
   <label>-</label>
   <p id="par0205">Active mechanisms include a direct action of viral proteins on transcription factors and intracellular signaling molecules that regulate the IFN cascade. In particular, the SARS-CoV protein ORF6 is able to inhibit the action of interferon regulatory transcription factor-3 (IRF-3), a transcription factor of the IFN genes [
    <xref rid="bib0415" ref-type="bibr">83</xref>,
    <xref rid="bib0420" ref-type="bibr">84</xref>].
   </p>
  </list-item>
 </list>
</p>
